Contraceptives Market - Global Outlook and Forecast 2022-2028

Contraceptives Market - Global Outlook and Forecast 2022-2028

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Contraceptives Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by End User
1.3 Global Contraceptives Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Contraceptives Overall Market Size
2.1 Global Contraceptives Market Size: 2021 VS 2028
2.2 Global Contraceptives Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Contraceptives Sales: 2017-2028
3 Company Landscape
3.1 Top Contraceptives Players in Global Market
3.2 Top Global Contraceptives Companies Ranked by Revenue
3.3 Global Contraceptives Revenue by Companies
3.4 Global Contraceptives Sales by Companies
3.5 Global Contraceptives Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Contraceptives Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Contraceptives Product Type
3.8 Tier 1, Tier 2 and Tier 3 Contraceptives Players in Global Market
3.8.1 List of Global Tier 1 Contraceptives Companies
3.8.2 List of Global Tier 2 and Tier 3 Contraceptives Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Contraceptives Market Size Markets, 2021 & 2028
4.1.2 Pills
4.1.3 Injectable
4.1.4 Condoms
4.1.5 Vaginal Rings
4.1.6 IUDs
4.1.7 Subdermal Implants
4.1.8 Others
4.2 By Type - Global Contraceptives Revenue & Forecasts
4.2.1 By Type - Global Contraceptives Revenue, 2017-2022
4.2.2 By Type - Global Contraceptives Revenue, 2023-2028
4.2.3 By Type - Global Contraceptives Revenue Market Share, 2017-2028
4.3 By Type - Global Contraceptives Sales & Forecasts
4.3.1 By Type - Global Contraceptives Sales, 2017-2022
4.3.2 By Type - Global Contraceptives Sales, 2023-2028
4.3.3 By Type - Global Contraceptives Sales Market Share, 2017-2028
4.4 By Type - Global Contraceptives Price (Manufacturers Selling Prices), 2017-2028
5 Sights By End User
5.1 Overview
5.1.1 By End User - Global Contraceptives Market Size, 2021 & 2028
5.1.2 15-24 years
5.1.3 25-34 years
5.1.4 35-44 years
5.1.5 Above 44 years
5.2 By End User - Global Contraceptives Revenue & Forecasts
5.2.1 By End User - Global Contraceptives Revenue, 2017-2022
5.2.2 By End User - Global Contraceptives Revenue, 2023-2028
5.2.3 By End User - Global Contraceptives Revenue Market Share, 2017-2028
5.3 By End User - Global Contraceptives Sales & Forecasts
5.3.1 By End User - Global Contraceptives Sales, 2017-2022
5.3.2 By End User - Global Contraceptives Sales, 2023-2028
5.3.3 By End User - Global Contraceptives Sales Market Share, 2017-2028
5.4 By End User - Global Contraceptives Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Contraceptives Market Size, 2021 & 2028
6.2 By Region - Global Contraceptives Revenue & Forecasts
6.2.1 By Region - Global Contraceptives Revenue, 2017-2022
6.2.2 By Region - Global Contraceptives Revenue, 2023-2028
6.2.3 By Region - Global Contraceptives Revenue Market Share, 2017-2028
6.3 By Region - Global Contraceptives Sales & Forecasts
6.3.1 By Region - Global Contraceptives Sales, 2017-2022
6.3.2 By Region - Global Contraceptives Sales, 2023-2028
6.3.3 By Region - Global Contraceptives Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Contraceptives Revenue, 2017-2028
6.4.2 By Country - North America Contraceptives Sales, 2017-2028
6.4.3 US Contraceptives Market Size, 2017-2028
6.4.4 Canada Contraceptives Market Size, 2017-2028
6.4.5 Mexico Contraceptives Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Contraceptives Revenue, 2017-2028
6.5.2 By Country - Europe Contraceptives Sales, 2017-2028
6.5.3 Germany Contraceptives Market Size, 2017-2028
6.5.4 France Contraceptives Market Size, 2017-2028
6.5.5 U.K. Contraceptives Market Size, 2017-2028
6.5.6 Italy Contraceptives Market Size, 2017-2028
6.5.7 Russia Contraceptives Market Size, 2017-2028
6.5.8 Nordic Countries Contraceptives Market Size, 2017-2028
6.5.9 Benelux Contraceptives Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Contraceptives Revenue, 2017-2028
6.6.2 By Region - Asia Contraceptives Sales, 2017-2028
6.6.3 China Contraceptives Market Size, 2017-2028
6.6.4 Japan Contraceptives Market Size, 2017-2028
6.6.5 South Korea Contraceptives Market Size, 2017-2028
6.6.6 Southeast Asia Contraceptives Market Size, 2017-2028
6.6.7 India Contraceptives Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Contraceptives Revenue, 2017-2028
6.7.2 By Country - South America Contraceptives Sales, 2017-2028
6.7.3 Brazil Contraceptives Market Size, 2017-2028
6.7.4 Argentina Contraceptives Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Contraceptives Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Contraceptives Sales, 2017-2028
6.8.3 Turkey Contraceptives Market Size, 2017-2028
6.8.4 Israel Contraceptives Market Size, 2017-2028
6.8.5 Saudi Arabia Contraceptives Market Size, 2017-2028
6.8.6 UAE Contraceptives Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Bayer AG
7.1.1 Bayer AG Corporate Summary
7.1.2 Bayer AG Business Overview
7.1.3 Bayer AG Contraceptives Major Product Offerings
7.1.4 Bayer AG Contraceptives Sales and Revenue in Global (2017-2022)
7.1.5 Bayer AG Key News
7.2 Pfizer, Inc
7.2.1 Pfizer, Inc Corporate Summary
7.2.2 Pfizer, Inc Business Overview
7.2.3 Pfizer, Inc Contraceptives Major Product Offerings
7.2.4 Pfizer, Inc Contraceptives Sales and Revenue in Global (2017-2022)
7.2.5 Pfizer, Inc Key News
7.3 Teva Pharmaceutical Industries Ltd
7.3.1 Teva Pharmaceutical Industries Ltd Corporate Summary
7.3.2 Teva Pharmaceutical Industries Ltd Business Overview
7.3.3 Teva Pharmaceutical Industries Ltd Contraceptives Major Product Offerings
7.3.4 Teva Pharmaceutical Industries Ltd Contraceptives Sales and Revenue in Global (2017-2022)
7.3.5 Teva Pharmaceutical Industries Ltd Key News
7.4 Merck & Co., Inc
7.4.1 Merck & Co., Inc Corporate Summary
7.4.2 Merck & Co., Inc Business Overview
7.4.3 Merck & Co., Inc Contraceptives Major Product Offerings
7.4.4 Merck & Co., Inc Contraceptives Sales and Revenue in Global (2017-2022)
7.4.5 Merck & Co., Inc Key News
7.5 Actavis, Inc.
7.5.1 Actavis, Inc. Corporate Summary
7.5.2 Actavis, Inc. Business Overview
7.5.3 Actavis, Inc. Contraceptives Major Product Offerings
7.5.4 Actavis, Inc. Contraceptives Sales and Revenue in Global (2017-2022)
7.5.5 Actavis, Inc. Key News
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Corporate Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Contraceptives Major Product Offerings
7.6.4 Johnson & Johnson Contraceptives Sales and Revenue in Global (2017-2022)
7.6.5 Johnson & Johnson Key News
7.7 Gedeon Richter
7.7.1 Gedeon Richter Corporate Summary
7.7.2 Gedeon Richter Business Overview
7.7.3 Gedeon Richter Contraceptives Major Product Offerings
7.7.4 Gedeon Richter Contraceptives Sales and Revenue in Global (2017-2022)
7.7.5 Gedeon Richter Key News
7.8 Novo Nordisk A/S
7.8.1 Novo Nordisk A/S Corporate Summary
7.8.2 Novo Nordisk A/S Business Overview
7.8.3 Novo Nordisk A/S Contraceptives Major Product Offerings
7.8.4 Novo Nordisk A/S Contraceptives Sales and Revenue in Global (2017-2022)
7.8.5 Novo Nordisk A/S Key News
7.9 ZiZhu
7.9.1 ZiZhu Corporate Summary
7.9.2 ZiZhu Business Overview
7.9.3 ZiZhu Contraceptives Major Product Offerings
7.9.4 ZiZhu Contraceptives Sales and Revenue in Global (2017-2022)
7.9.5 ZiZhu Key News
7.10 Baijingyu
7.10.1 Baijingyu Corporate Summary
7.10.2 Baijingyu Business Overview
7.10.3 Baijingyu Contraceptives Major Product Offerings
7.10.4 Baijingyu Contraceptives Sales and Revenue in Global (2017-2022)
7.10.5 Baijingyu Key News
7.11 Huazhong
7.11.1 Huazhong Corporate Summary
7.11.2 Huazhong Contraceptives Business Overview
7.11.3 Huazhong Contraceptives Major Product Offerings
7.11.4 Huazhong Contraceptives Sales and Revenue in Global (2017-2022)
7.11.5 Huazhong Key News
7.12 Sine
7.12.1 Sine Corporate Summary
7.12.2 Sine Contraceptives Business Overview
7.12.3 Sine Contraceptives Major Product Offerings
7.12.4 Sine Contraceptives Sales and Revenue in Global (2017-2022)
7.12.5 Sine Key News
7.13 Reckitt
7.13.1 Reckitt Corporate Summary
7.13.2 Reckitt Contraceptives Business Overview
7.13.3 Reckitt Contraceptives Major Product Offerings
7.13.4 Reckitt Contraceptives Sales and Revenue in Global (2017-2022)
7.13.5 Reckitt Key News
7.14 AbbVie
7.14.1 AbbVie Corporate Summary
7.14.2 AbbVie Business Overview
7.14.3 AbbVie Contraceptives Major Product Offerings
7.14.4 AbbVie Contraceptives Sales and Revenue in Global (2017-2022)
7.14.5 AbbVie Key News
7.15 Church & Dwight
7.15.1 Church & Dwight Corporate Summary
7.15.2 Church & Dwight Business Overview
7.15.3 Church & Dwight Contraceptives Major Product Offerings
7.15.4 Church & Dwight Contraceptives Sales and Revenue in Global (2017-2022)
7.15.5 Church & Dwight Key News
7.16 The Cooper Companies
7.16.1 The Cooper Companies Corporate Summary
7.16.2 The Cooper Companies Business Overview
7.16.3 The Cooper Companies Contraceptives Major Product Offerings
7.16.4 The Cooper Companies Contraceptives Sales and Revenue in Global (2017-2022)
7.16.5 The Cooper Companies Key News
7.17 TherapeuticsMD
7.17.1 TherapeuticsMD Corporate Summary
7.17.2 TherapeuticsMD Business Overview
7.17.3 TherapeuticsMD Contraceptives Major Product Offerings
7.17.4 TherapeuticsMD Contraceptives Sales and Revenue in Global (2017-2022)
7.17.5 TherapeuticsMD Key News
7.18 Afaxys
7.18.1 Afaxys Corporate Summary
7.18.2 Afaxys Business Overview
7.18.3 Afaxys Contraceptives Major Product Offerings
7.18.4 Afaxys Contraceptives Sales and Revenue in Global (2017-2022)
7.18.5 Afaxys Key News
7.19 Mithra Pharmaceuticals
7.19.1 Mithra Pharmaceuticals Corporate Summary
7.19.2 Mithra Pharmaceuticals Business Overview
7.19.3 Mithra Pharmaceuticals Contraceptives Major Product Offerings
7.19.4 Mithra Pharmaceuticals Contraceptives Sales and Revenue in Global (2017-2022)
7.19.5 Mithra Pharmaceuticals Key News
8 Global Contraceptives Production Capacity, Analysis
8.1 Global Contraceptives Production Capacity, 2017-2028
8.2 Contraceptives Production Capacity of Key Manufacturers in Global Market
8.3 Global Contraceptives Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Contraceptives Supply Chain Analysis
10.1 Contraceptives Industry Value Chain
10.2 Contraceptives Upstream Market
10.3 Contraceptives Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Contraceptives Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Contraceptives in Global Market
Table 2. Top Contraceptives Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Contraceptives Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Contraceptives Revenue Share by Companies, 2017-2022
Table 5. Global Contraceptives Sales by Companies, (M Units), 2017-2022
Table 6. Global Contraceptives Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Contraceptives Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Contraceptives Product Type
Table 9. List of Global Tier 1 Contraceptives Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Contraceptives Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Contraceptives Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Contraceptives Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Contraceptives Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Contraceptives Sales (M Units), 2017-2022
Table 15. By Type - Global Contraceptives Sales (M Units), 2023-2028
Table 16. By End User - Global Contraceptives Revenue, (US$, Mn), 2021 & 2028
Table 17. By End User - Global Contraceptives Revenue (US$, Mn), 2017-2022
Table 18. By End User - Global Contraceptives Revenue (US$, Mn), 2023-2028
Table 19. By End User - Global Contraceptives Sales (M Units), 2017-2022
Table 20. By End User - Global Contraceptives Sales (M Units), 2023-2028
Table 21. By Region - Global Contraceptives Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Contraceptives Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Contraceptives Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Contraceptives Sales (M Units), 2017-2022
Table 25. By Region - Global Contraceptives Sales (M Units), 2023-2028
Table 26. By Country - North America Contraceptives Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Contraceptives Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Contraceptives Sales, (M Units), 2017-2022
Table 29. By Country - North America Contraceptives Sales, (M Units), 2023-2028
Table 30. By Country - Europe Contraceptives Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Contraceptives Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Contraceptives Sales, (M Units), 2017-2022
Table 33. By Country - Europe Contraceptives Sales, (M Units), 2023-2028
Table 34. By Region - Asia Contraceptives Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Contraceptives Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Contraceptives Sales, (M Units), 2017-2022
Table 37. By Region - Asia Contraceptives Sales, (M Units), 2023-2028
Table 38. By Country - South America Contraceptives Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Contraceptives Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Contraceptives Sales, (M Units), 2017-2022
Table 41. By Country - South America Contraceptives Sales, (M Units), 2023-2028
Table 42. By Country - Middle East & Africa Contraceptives Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Contraceptives Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Contraceptives Sales, (M Units), 2017-2022
Table 45. By Country - Middle East & Africa Contraceptives Sales, (M Units), 2023-2028
Table 46. Bayer AG Corporate Summary
Table 47. Bayer AG Contraceptives Product Offerings
Table 48. Bayer AG Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Pfizer, Inc Corporate Summary
Table 50. Pfizer, Inc Contraceptives Product Offerings
Table 51. Pfizer, Inc Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Teva Pharmaceutical Industries Ltd Corporate Summary
Table 53. Teva Pharmaceutical Industries Ltd Contraceptives Product Offerings
Table 54. Teva Pharmaceutical Industries Ltd Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Merck & Co., Inc Corporate Summary
Table 56. Merck & Co., Inc Contraceptives Product Offerings
Table 57. Merck & Co., Inc Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Actavis, Inc. Corporate Summary
Table 59. Actavis, Inc. Contraceptives Product Offerings
Table 60. Actavis, Inc. Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Johnson & Johnson Corporate Summary
Table 62. Johnson & Johnson Contraceptives Product Offerings
Table 63. Johnson & Johnson Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Gedeon Richter Corporate Summary
Table 65. Gedeon Richter Contraceptives Product Offerings
Table 66. Gedeon Richter Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Novo Nordisk A/S Corporate Summary
Table 68. Novo Nordisk A/S Contraceptives Product Offerings
Table 69. Novo Nordisk A/S Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. ZiZhu Corporate Summary
Table 71. ZiZhu Contraceptives Product Offerings
Table 72. ZiZhu Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Baijingyu Corporate Summary
Table 74. Baijingyu Contraceptives Product Offerings
Table 75. Baijingyu Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Huazhong Corporate Summary
Table 77. Huazhong Contraceptives Product Offerings
Table 78. Huazhong Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Sine Corporate Summary
Table 80. Sine Contraceptives Product Offerings
Table 81. Sine Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. Reckitt Corporate Summary
Table 83. Reckitt Contraceptives Product Offerings
Table 84. Reckitt Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 85. AbbVie Corporate Summary
Table 86. AbbVie Contraceptives Product Offerings
Table 87. AbbVie Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 88. Church & Dwight Corporate Summary
Table 89. Church & Dwight Contraceptives Product Offerings
Table 90. Church & Dwight Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 91. The Cooper Companies Corporate Summary
Table 92. The Cooper Companies Contraceptives Product Offerings
Table 93. The Cooper Companies Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 94. TherapeuticsMD Corporate Summary
Table 95. TherapeuticsMD Contraceptives Product Offerings
Table 96. TherapeuticsMD Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 97. Afaxys Corporate Summary
Table 98. Afaxys Contraceptives Product Offerings
Table 99. Afaxys Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 100. Mithra Pharmaceuticals Corporate Summary
Table 101. Mithra Pharmaceuticals Contraceptives Product Offerings
Table 102. Mithra Pharmaceuticals Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 103. Contraceptives Production Capacity (M Units) of Key Manufacturers in Global Market, 2020-2022 (M Units)
Table 104. Global Contraceptives Capacity Market Share of Key Manufacturers, 2020-2022
Table 105. Global Contraceptives Production by Region, 2017-2022 (M Units)
Table 106. Global Contraceptives Production by Region, 2023-2028 (M Units)
Table 107. Contraceptives Market Opportunities & Trends in Global Market
Table 108. Contraceptives Market Drivers in Global Market
Table 109. Contraceptives Market Restraints in Global Market
Table 110. Contraceptives Raw Materials
Table 111. Contraceptives Raw Materials Suppliers in Global Market
Table 112. Typical Contraceptives Downstream
Table 113. Contraceptives Downstream Clients in Global Market
Table 114. Contraceptives Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Contraceptives Segment by Type
Figure 2. Contraceptives Segment by End User
Figure 3. Global Contraceptives Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Contraceptives Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Contraceptives Revenue, 2017-2028 (US$, Mn)
Figure 7. Contraceptives Sales in Global Market: 2017-2028 (M Units)
Figure 8. The Top 3 and 5 Players Market Share by Contraceptives Revenue in 2021
Figure 9. By Type - Global Contraceptives Sales Market Share, 2017-2028
Figure 10. By Type - Global Contraceptives Revenue Market Share, 2017-2028
Figure 11. By Type - Global Contraceptives Price (USD/Unit), 2017-2028
Figure 12. By End User - Global Contraceptives Sales Market Share, 2017-2028
Figure 13. By End User - Global Contraceptives Revenue Market Share, 2017-2028
Figure 14. By End User - Global Contraceptives Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Contraceptives Sales Market Share, 2017-2028
Figure 16. By Region - Global Contraceptives Revenue Market Share, 2017-2028
Figure 17. By Country - North America Contraceptives Revenue Market Share, 2017-2028
Figure 18. By Country - North America Contraceptives Sales Market Share, 2017-2028
Figure 19. US Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Contraceptives Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Contraceptives Sales Market Share, 2017-2028
Figure 24. Germany Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 25. France Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Contraceptives Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Contraceptives Sales Market Share, 2017-2028
Figure 33. China Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 37. India Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Contraceptives Revenue Market Share, 2017-2028
Figure 39. By Country - South America Contraceptives Sales Market Share, 2017-2028
Figure 40. Brazil Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Contraceptives Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Contraceptives Sales Market Share, 2017-2028
Figure 44. Turkey Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Contraceptives Revenue, (US$, Mn), 2017-2028
Figure 48. Global Contraceptives Production Capacity (M Units), 2017-2028
Figure 49. The Percentage of Production Contraceptives by Region, 2020 VS 2027
Figure 50. Contraceptives Industry Value Chain
Figure 51. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Drugs for Vulvovaginal Candidiasis Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119

According to our LPI (LP Information) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at US$ 798.8 million in 2023. With growing demand in downstream market, the Drugs for Vulvovaginal Candidiasis is forecast to a readjusted size of US$ 890 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Drugs for Vulvovaginal Candidiasis market. Drugs for Vulvovaginal Candidiasis are expected t......

Global Bacterial Vaginosis Drug Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132

According to our LPI (LP Information) latest study, the global Bacterial Vaginosis Drug market size was valued at US$ 896.6 million in 2023. With growing demand in downstream market, the Bacterial Vaginosis Drug is forecast to a readjusted size of US$ 1111.1 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Bacterial Vaginosis Drug market. Bacterial Vaginosis Drug are expected to show stable growth in the future ma......

Global Contraceptives Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 141

According to our LPI (LP Information) latest study, the global Contraceptives market size was valued at US$ 1870.3 million in 2023. With growing demand in downstream market, the Contraceptives is forecast to a readjusted size of US$ 2237.4 million by 2030 with a CAGR of 2.6% during review period. The research report highlights the growth potential of the global Contraceptives market. Contraceptives are expected to show stable growth in the future market. However, product differentiation,......

Global Drugs for Vulvovaginal Candidiasis Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 108

According to our (Global Info Research) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at USD 840.2 million in 2023 and is forecast to a readjusted size of USD 928.4 million by 2030 with a CAGR of 1.4% during review period. The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cu......

Global Menopausal Hot Flashes Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 99

Market Overview of Global Menopausal Hot Flashes market: According to our latest research, the global Menopausal Hot Flashes market looks promising in the next 5 years. As of 2022, the global Menopausal Hot Flashes market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Hot flashes during menopause are symptoms of menopause. They refer to the warmth that occurs during the transition period of ......

Global Bacterial Vaginosis Drug Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 139

Report Overview: This report studies the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. This report includes metronidazole, clindamycin drug and other drugs. The Global Bacterial Vaginosis Drug Market Size was estimated at USD 916.50 million in 2022 and is projected to reach USD 1127.18 million by 202......

Global Drugs for Vulvovaginal Candidiasis Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 122

Report Overview: The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for a......

Global Bacterial Vaginosis Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 108

Market Overview of Global Bacterial Vaginosis Drug market: According to our latest research, the global Bacterial Vaginosis Drug market looks promising in the next 5 years. As of 2022, the global Bacterial Vaginosis Drug market was estimated at USD 972.77 million, and it's anticipated to reach USD 1215.68 million in 2028, with a CAGR of 3.79% during the forecast years. Bacterial vaginosis (BV), also known as bacterial vaginosis, non-specific vaginitis is a disease that occurs......

Global Tocolysis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 123

Market Overview of Global Tocolysis Drugs market: According to our latest research, the global Tocolysis Drugs market looks promising in the next 5 years. As of 2022, the global Tocolysis Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Tocolytics are medications used to suppress premature labor. Tocolytic therapy is provided when delivery would result in premature birth, postponi......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs